單一療法
Sulfasalazine monotherapy is recommended for patients with all disease durations and without poor prognostic features and includes those with all degrees of disease activity. 柳氮磺吡啶單一療法為那些長期患有各種疾病和沒有不良預(yù)后特征的，包含那些不同嚴重程度患病的患者推薦。
